Sovaldi and Agranulocytosis - a phase IV clinical study of FDA data
Summary:
Agranulocytosis is reported as a side effect among people who take Sovaldi (sofosbuvir), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Pegasys, and have Hepatitis c.
The phase IV clinical study analyzes which people have Agranulocytosis when taking Sovaldi. It is created by eHealthMe based on reports of 12,681 people who have side effects when taking Sovaldi from the FDA, and is updated regularly.
What is Sovaldi?
Sovaldi has active ingredients of sofosbuvir. eHealthMe is studying from 12,697 Sovaldi users. Check the latest studies of Sovaldi.
What is Agranulocytosis?
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,327 drugs and 3,594 conditions by eHealthMe. Check the latest studies of Agranulocytosis.
12,681 people reported to have side effects when taking Sovaldi.
Among them, 110 people (0.87%) have Agranulocytosis.

Among these 110 people:
How long have people been on Sovaldi when they have Agranulocytosis? *
What is the gender of people who have Agranulocytosis when taking Sovaldi? *
What is the age of people who have Agranulocytosis when taking Sovaldi? *
What are other drugs people take besides Sovaldi? *
What are other side effects people have besides Agranulocytosis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Sovaldi and have Agranulocytosis?
- Check whether Agranulocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sovaldi:
- Sovaldi (12,697 reports)
Agranulocytosis treatments and more:
- Agranulocytosis (213,267 reports)
How severe was Agranulocytosis and when was it recovered:
Expand to all the drugs that have ingredients of sofosbuvir:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sovaldi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Agranulocytosis:
- Agranulocytosis (2,327 drugs)
Browse all the conditions that are associated with Agranulocytosis:
- Agranulocytosis (3,594 conditions)
Related publications that referenced our studies
- Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
- Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on sofosbuvir (the active ingredients of Sovaldi) and Sovaldi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Listless and drugs of ingredients of lenalidomide - a second ago
- Drug interactions of Zithromax and Primrose Oil - 16 seconds ago
- Could Valium cause Peritonitis? - 47 seconds ago
- Could Aspirin cause Benign Hepatic Neoplasm? - 50 seconds ago
- Abdominal Pain in Ondansetron, how severe and when it was recovered? - 55 seconds ago
- Allegra and Epinephrine drug interactions for men aged 50-59 - 57 seconds ago
- Could Emla cause Arthropathy? - a minute ago
- Irritable Bowel Syndrome in Magnesium Chloride, how severe and when it was recovered? - a minute ago
- Could Imodium cause Blood Urea Decreased? - a minute ago
- Magnesium Oxide vs. Prochlorperazine, side effect and effectiveness comparison - a minute ago